News
By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...
Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease.
Share on Pinterest New research suggests that HIV drugs may have a protective effect against Alzheimer’s. Willie B. Thomas/Getty Images Researchers at UVA Health have found that a class of HIV ...
Adam Hall has been charged with five counts of rape and seven counts of causing grievous bodily harm, which relate to the ...
Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.
10d
AP Newsroom on MSNHealth officials in Haiti meet to discuss shortage of HIV/AIDS medication after protestsA work group in Haiti with health officials and representatives from various organizations met in Port-au-Prince on Monday to discuss the shortage of the medication essential to keep HIV /AIDS ...
17h
Futurism on MSN"Gasping": Scientists Make Breakthrough Toward Full Cure for HIVScientists found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body ...
There’s no cure yet for HIV or stage 3 HIV, also known as AIDS ... fumarate in the drug Delstrigo) nevirapine (Viramune, Viramune XR) Entry inhibitors are a class of drugs that block HIV ...
This key observation was vital, as no other types of HIV medications showed a similar protective effect. Thus, inflammasome-blocking appears uniquely beneficial. Previous research had already ...
A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...
The researchers note that patients taking other types of HIV medications did not show the same reduction in Alzheimer’s risk as those on NRTIs. Based on that, they say that NRTIs warrant clinical ...
Researchers meeting at the 11th Annual AIDS Conference in Vancouver, Canada, this week focused the international spotlight on a new class of drugs known as protease inhibitors. Used in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results